Skip to main content
Premium Trial:

Request an Annual Quote

Doctors' Network to Offer Navigenics' Genotype Test

NEW YORK (GenomeWeb News) – Navigenics will provide its genomic testing service through a network of physicians in order to help their patients learn about their potential genetic risks for certain diseases, Navigenics said today.
Under the agreement, Navigenics will provide its services to doctors in the MDVIP network, which is spread across 25 states and Washington, DC. These physicians practice preventive, proactive, and personalized healthcare, the company said.
The Navigenics test will be used to identify markers that could indicate a patient’s risk levels for developing conditions such as type 2 diabetes, cancer, heart attack, and celiac disease.
Navigenics said it spent six months working with MDVIP studying how doctors and patients integrated preventive genomics in more than 40 clinical encounters.
MDVIP CEO Edward Goldman said in a statement that patients involved in the study “overwhelmingly found the experience positive, they felt empowered rather than anxious, and they indicated a desire to change their lifestyles and more productively work with their physicians.”
The network of 280 doctors, which serves over 100,000 patients, will discuss the testing process with patients. Patients may also consult with a genetic counselor, and Navigenics will conduct the genome scanning and the personal risk analysis.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.